Home › Funds › Legacy Advisors, LLC › ABBV

Legacy Advisors, LLC position in ABBV

ABBVIE INC · Health Care

Legacy Advisors, LLC reported holding 16,549 shares of ABBV (ABBVIE INC) in its Q2 2026 13F filing — a position valued at US$4.2M, representing 0.39% of its reported portfolio and ranking #41 among its reported holdings. Legacy Advisors, LLC has disclosed ABBV holdings in 11 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)16.55K sh
Reported value held$4.16M
Portfolio Weight0.39%
First reportedQ3 2023
Last changeNew

How Legacy Advisors, LLC's ABBV position evolved

Legacy Advisors, LLC first disclosed a stake in ABBV in Q3 2023 at 20,804 shares (US$3.1M). The position peaked in Q1 2025 at 21,983 shares, worth US$4.6M. Across 11 filings, Legacy Advisors, LLC increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 16,549 shares valued at US$4.2M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 20.80K $3.10M New
Q4 2023 19.05K $2.95M Reduce
Q1 2024 19.82K $3.61M Add
Q2 2024 19.87K $3.41M Hold
Q3 2024 21.90K $4.32M Add
Q4 2024 20.81K $3.70M Reduce
Q1 2025 21.98K $4.61M Add
Q3 2025 14.70K $3.40M New
Q4 2025 15.65K $3.58M Add
Q1 2026 15.23K $3.31M Reduce
Q2 2026 16.55K $4.16M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →